NCT05726903View on ClinicalTrials.gov

Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone

PHASE4RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

December 1, 2026

Study Completion Date

June 1, 2027

Conditions

Gender Dysphoria, Adolescent

Interventions

DRUG

Depo-subQ Provera Injectable Product

SC Injection at Home

Trial Locations (1)

80230

RECRUITING

Comprehensive Women's Health Center, Denver

All Listed Sponsors

lead

University of Colorado, Denver

OTHER